Patents Assigned to Mazence Inc. - Justia Patents Search

Patents Assigned to Mazence Inc.

Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

Patent number: 8404869

Abstract: Provided is a pharmaceutical composition for the treatment and/or prevention of disease involving metabolic syndromes, comprising (a) a therapeutically effective amount of a particular compound represented by Formula 1 as defined in the specification, or isomer, prodrug, or solvate or thereof, and (b) a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.

Type: Grant

Filed: April 25, 2008

Date of Patent: March 26, 2013

Assignees: Mazence Inc., KT & G Co., Ltd.

Inventors: Sang-Ku Yoo, Ku Suk Kang, Sang Woo Yoo, Taehwan Kwak
USE OF PRODRUG COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR MANUFACTURE OF MEDICAMENT FOR TREATMENT OR PREVENTION OF DISEASES INVOLVING METABOLIC SYNDROME

Publication number: 20090124680

Abstract: Provided is a use of a prodrug composition containing a naphthoquinone-based compound of Formula 1 for the manufacture of a medicament for treatment or prevention of metabolic syndrome diseases. wherein R1 to R10, X, m and n are as defined in the specification.

Type: Application

Filed: October 30, 2008

Publication date: May 14, 2009

Applicants: Mazence Inc., KT&G Corporation

Inventors: Sang-Ku YOO, Sang Woo YOO, Ku Suk KANG